News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

Paul Cézanne. Pyramid of Skulls, oil on canvas, c. 1901.
By Peter Aldhous, BuzzFeed | 05.11.2016
Untitled Document

Esteban Burchard is pissed. He’s angry that people of color are being sidelined by a medical revolution spawned...

By Robert Weisman, The Boston Globe | 05.11.2016
Untitled Document

A trio of startup companies rooted in the local life-sciences community is focusing on a task long seen...

By Sharon Begley, STAT | 05.11.2016
Untitled Document

The largest study of its kind has found 74 genetic variants that influence how many years of school...

By Drew Endy and Laurie Zoloth, DSpace@MIT | 05.10.2016

At Harvard today an invitation-only group of mostly scientists, lawyers, and entrepreneurs, ~150 in total, met to discuss if and...

A woman and child stand in front of Sri Harmandir Sahib aka the Golden Temple in Amritsar, India. (Pixabay)
By Andrew Marszal, The Telegraph [UK] | 05.10.2016
Untitled Document An Indian woman has given birth to her first child at the age of 72 after undergoing fertility...
By Michael Cook, BioEdge | 05.07.2016
Untitled Document

What does the American public think about human germline enhancement? A survey of 17 polls taken over the...

By Antonio Regalado, MIT Technology Review | 05.06.2016

A treatment now pending approval in Europe will be the first commercial gene therapy to provide an outright cure for...

UniQure's Glybera aka alipogene tiparvovec.
By Antonio Regalado, MIT Technology Review | 05.05.2016
Untitled Document

The most expensive drug in history is a money loser that’s not reaching patients. In fact, it’s only been...